Your Bloods Are ‘Normal’. So Why Does Your Body Feel Completely Out of Sync?

Standard hormone panels typically measure FSH, LH, and sometimes oestradiol. These markers can confirm whether you are approaching menopause, but they do not explain why you feel the way you do. They do not measure oestrogen metabolites, the 2:16 OH oestrone ratio, progesterone metabolites like allopregnanolone, DHEA-S, cortisol rhythm, or the endocrine disruptors that interfere with hormone signalling. In many cases, the symptoms are driven by how hormones are being processed and cleared — not by whether they are present.

Menopause is defined as 12 consecutive months without a menstrual period. Perimenopause is the transitional phase leading up to it — which can last anywhere from 2 to 12 years. During perimenopause, hormone levels fluctuate unpredictably. Progesterone tends to decline first, oestrogen can swing between high and low, and the adrenal glands are called on to compensate. Most of the symptoms people associate with menopause — hot flushes, anxiety, fatigue, brain fog, weight changes — actually begin in perimenopause, often years before periods stop.

Yes, but the type of testing matters. Standard blood tests offer a single snapshot of fluctuating hormones. Functional hormone testing — such as the DUTCH test or the Vibrant Wellness Hormone Zoomer — measures hormones and their metabolites over time, revealing how oestrogen is being metabolised through the 2-OH, 4-OH, and 16-OH pathways, whether progesterone is converting to calming metabolites like allopregnanolone, and whether adrenal hormones are compensating appropriately. This level of detail is what allows a targeted protocol rather than a generic one.

HRT can be an effective tool for managing specific symptoms, and many women benefit from it. But it is not the only option, and it does not address many of the underlying patterns that drive perimenopausal symptoms — including adrenal burden, oestrogen metabolism dysfunction, gut-mediated hormone recirculation, nutrient deficiencies, and endocrine disruptor exposure. Functional investigation identifies which of these patterns is active in your case, so that any intervention — whether HRT, nutritional, or both — is targeted rather than generic.

A significant one. The gut contains a collection of bacteria known as the oestrobolome, which produces an enzyme called beta-glucuronidase. This enzyme determines whether oestrogen is excreted or reabsorbed into circulation. When gut bacteria are disrupted — through dysbiosis, antibiotic use, or poor diet — beta-glucuronidase activity can increase, leading to oestrogen recirculation and a state of relative oestrogen dominance. This is one of the most common and most overlooked contributing factors in perimenopausal symptoms.

Endocrine disruptors are chemicals that mimic or block natural hormone signalling. Common examples include BPA (found in plastics), phthalates (found in fragrances and packaging), parabens (found in cosmetics), and glyphosate (a widely used herbicide). These compounds can bind to oestrogen receptors, interfere with thyroid function, and disrupt the adrenal stress response. In many cases, they are a contributing factor in hormone-related symptoms that do not resolve with standard approaches. They are testable — and rarely considered in standard investigation.

In many cases, yes. Many clients report significant improvement when the underlying drivers are identified and addressed — including oestrogen metabolism dysfunction, adrenal burden, gut-mediated hormone recirculation, nutrient deficiencies, and environmental hormone disruptors. The timeline varies: in Paul’s clinical experience, many clients notice improvement within the first weeks of a targeted protocol, with more substantial changes emerging over three to six months. Medication is not excluded from this process — but it is rarely the whole answer.

A typical programme runs three to six months, depending on the complexity of the presentation. It begins with a detailed case review and targeted testing, followed by a sequenced protocol that addresses the identified drivers in the right order. Many clients report noticeable improvement within the first weeks. The goal is not indefinite treatment — it is to identify what is driving the symptoms, address it systematically, and build a sustainable foundation.